title: Select-agent status could slow development of anti-SARS therapies.
authors.forename: Susan
authors.initials: S
authors.lastname: Matthews
mesh_terms: D023482:Bioterrorism / Q000517:prevention & control*; D002487:Centers for Disease Control and Prevention, U.S.; D033161:Government Regulation; D006801:Humans; D012106:Research; D045473:Severe acute respiratory syndrome-related coronavirus / Q000145:classification*; D045169:Severe Acute Respiratory Syndrome / Q000188:drug therapy* / Q000821:virology*; D014481:United States